Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs. Placebo for Severe Alcohol Withdrawal
NCT02823977Phase 4Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Feb 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in alcohol withdrawal syndrome (AWS), sponsored by University of Colorado Denver. Planned start Feb 2018; status: withdrawn.
02
Drugs
ketamine
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT02823977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02823977.